Aelis Farma SA (EPA:AELIS)

Aelis Farma Statistics

Total Valuation

Aelis Farma has a market cap or net worth of EUR 15.02 million. The enterprise value is 11.12 million.

Market Cap	15.02M
Enterprise Value	11.12M

Important Dates

The next estimated earnings date is Tuesday, December 23, 2025.

Earnings Date	Dec 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Aelis Farma has 13.59 million shares outstanding. The number of shares has increased by 3.44% in one year.

Current Share Class	13.59M
Shares Outstanding	13.59M
Shares Change (YoY)	+3.44%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	38.34%
Owned by Institutions (%)	n/a
Float	3.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.44
PB Ratio	2.46
P/TBV Ratio	2.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.36
EV / Sales	4.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.47

Financial Position

The company has a current ratio of 3.18, with a Debt / Equity ratio of 1.13.

Current Ratio	3.18
Quick Ratio	3.11
Debt / Equity	1.13
Debt / EBITDA	n/a
Debt / FCF	-0.91
Interest Coverage	-32.62

Financial Efficiency

Return on equity (ROE) is -102.08% and return on invested capital (ROIC) is -36.65%.

Return on Equity (ROE)	-102.08%
Return on Assets (ROA)	-28.50%
Return on Invested Capital (ROIC)	-36.65%
Return on Capital Employed (ROCE)	-73.75%
Revenue Per Employee	97,208
Profits Per Employee	-341,500
Employee Count	28
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

In the past 12 months, Aelis Farma has paid 12,000 in taxes.

Income Tax	12,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -53.96% in the last 52 weeks. The beta is 0.46, so Aelis Farma's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-53.96%
50-Day Moving Average	1.13
200-Day Moving Average	1.17
Relative Strength Index (RSI)	49.91
Average Volume (20 Days)	41,122

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aelis Farma had revenue of EUR 2.33 million and -8.20 million in losses. Loss per share was -0.60.

Revenue	2.33M
Gross Profit	2.33M
Operating Income	-8.22M
Pretax Income	-8.18M
Net Income	-8.20M
EBITDA	-8.13M
EBIT	-8.22M
Loss Per Share	-0.60

Balance Sheet

The company has 10.79 million in cash and 6.89 million in debt, giving a net cash position of 3.90 million or 0.29 per share.

Cash & Cash Equivalents	10.79M
Total Debt	6.89M
Net Cash	3.90M
Net Cash Per Share	0.29
Equity (Book Value)	6.11M
Book Value Per Share	0.45
Working Capital	9.68M

Cash Flow

In the last 12 months, operating cash flow was -7.54 million and capital expenditures -31,000, giving a free cash flow of -7.57 million.

Operating Cash Flow	-7.54M
Capital Expenditures	-31,000
Free Cash Flow	-7.57M
FCF Per Share	-0.56

Margins

Gross Margin	100.00%
Operating Margin	-352.34%
Pretax Margin	-350.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Aelis Farma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.44%
Shareholder Yield	-3.44%
Earnings Yield	-54.57%
FCF Yield	-50.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aelis Farma has an Altman Z-Score of 2.28 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.28
Piotroski F-Score	1